T. Rowe Price Associates’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.32M | Buy |
68,661
+11,852
| +21% | +$258K | ﹤0.01% | 2007 |
|
|
2025
Q4 | $1.25M | Sell |
56,809
-8,994
| -14% | -$162K | ﹤0.01% | 1982 |
|
|
2025
Q3 | $799K | Buy |
65,803
+6,600
| +11% | +$89.3K | ﹤0.01% | 2158 |
|
|
2025
Q2 | $1.1M | Buy |
59,203
+6,360
| +12% | +$126K | ﹤0.01% | 1946 |
|
|
2025
Q1 | $1.01M | Buy |
52,843
+2,103
| +4% | +$61.5K | ﹤0.01% | 1953 |
|
|
2024
Q4 | $1.83M | Buy |
50,740
+5,540
| +12% | +$187K | ﹤0.01% | 1697 |
|
|
2024
Q3 | $1.92M | Buy |
45,200
+409
| +0.9% | +$17.3K | ﹤0.01% | 1662 |
|
|
2024
Q2 | $1.8M | Buy |
44,791
+6,059
| +16% | +$253K | ﹤0.01% | 1604 |
|
|
2024
Q1 | $1.37M | Buy |
38,732
+1,985
| +5% | +$53.2K | ﹤0.01% | 1749 |
|
|
2023
Q4 | $1.09M | Buy |
36,747
+1,931
| +6% | +$40.1K | ﹤0.01% | 1832 |
|
|
2023
Q3 | $724K | Buy |
34,816
+2,787
| +9% | +$76.5K | ﹤0.01% | 1946 |
|
|
2023
Q2 | $786K | Sell |
32,029
-259,162
| -89% | -$8.34M | ﹤0.01% | 1920 |
|
|
2023
Q1 | $11.8M | Buy |
291,191
+925
| +0.3% | +$38.3K | ﹤0.01% | 1025 |
|
|
2022
Q4 | $13M | Sell |
290,266
-113,679
| -28% | -$5.15M | ﹤0.01% | 1010 |
|
|
2022
Q3 | $19.3M | Sell |
403,945
-231,499
| -36% | -$12.7M | ﹤0.01% | 916 |
|
|
2022
Q2 | $37.6M | Buy |
635,444
+7,747
| +1% | +$636K | ﹤0.01% | 973 |
|
|
2022
Q1 | $73M | Buy |
627,697
+3,886
| +0.6% | +$454K | 0.01% | 835 |
|
|
2021
Q4 | $93.9M | Sell |
623,811
-26,494
| -4% | -$3.58M | 0.01% | 788 |
|
|
2021
Q3 | $77.6M | Sell |
650,305
-131,038
| -17% | -$14.4M | 0.01% | 853 |
|
|
2021
Q2 | $76.1M | Sell |
781,343
-312,972
| -29% | -$27.9M | 0.01% | 883 |
|
|
2021
Q1 | $96.6M | Sell |
1,094,315
-277,065
| -20% | -$25.7M | 0.01% | 790 |
|
|
2020
Q4 | $131M | Buy |
1,371,380
+42,692
| +3% | +$4.4M | 0.01% | 635 |
|
|
2020
Q3 | $151M | Buy |
1,328,688
+256,413
| +24% | +$26.9M | 0.02% | 548 |
|
|
2020
Q2 | $106M | Buy |
1,072,275
+579,116
| +117% | +$46.2M | 0.01% | 627 |
|
|
2020
Q1 | $31.7M | Buy |
493,159
+236,324
| +92% | +$16.6M | 0.01% | 925 |
|
|
2019
Q4 | $15.3M | Sell |
256,835
-34,582
| -12% | -$2.13M | ﹤0.01% | 1239 |
|
|
2019
Q3 | $17.2M | Buy |
291,417
+22,506
| +8% | +$1.44M | ﹤0.01% | 1199 |
|
|
2019
Q2 | $17.4M | Buy |
268,911
+20,198
| +8% | +$1.3M | ﹤0.01% | 1217 |
|
|
2019
Q1 | $15.8M | Buy |
248,713
+21,323
| +9% | +$1.12M | ﹤0.01% | 1241 |
|
|
2018
Q4 | $8.63M | Sell |
227,390
-19,502
| -8% | -$689K | ﹤0.01% | 1329 |
|
|
2018
Q3 | $10.6M | Buy |
+246,892
| New | +$8.62M | ﹤0.01% | 1358 |
|
Other funds holding TNDM
SC
VPM
ACH
VCM
GKIM
DCM
